Delivery Order SPE2DB22D3401-SPE2DB26FT0EV
Award Date 10/15/25
Potential Completion Date 10/16/25
Potential Value $9.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on May 22, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat inflammatory conditions. This is a firm fixed-price delivery order with a ceiling value of $4,531.80 and an ultimate completion date of May 23, 2025. The contract is non-competitive with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp received a $12,823.56 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 3, 2025, for HUMIRA (CF) Pen 40 mg/0.4 mls pharmaceutical products, with completion targeted for September 4, 2025. This non-set-aside contract will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a competitive award to the established pharmaceutical distributor, which maintains significant federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls with a ceiling value of $15,815.48 under a firm fixed-price contract. This delivery order represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made on a competitive basis with no set-aside...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on April 21, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a prescription immunosuppressant medication used to treat autoimmune diseases. This firm fixed-price delivery order, valued at $25,463.41, represents a non-competitive set-aside award with an ultimate completion date of April 22, 2025, and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $79,428.88 on September 29, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls under a firm fixed-price contract. This award was made without a set-aside designation through competitive procurement by the Defense Logistics Agency's Medical Supply Chain, with a completion date of September 30, 2025. The vendor, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order valued at $4,531.80 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on September 24, 2025, with completion scheduled for September 25, 2025. This firm fixed-price, non-set-aside contract represents a pharmaceutical supply delivery to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $3,174.48 delivery order to AmerisourceBergen Drug Corp for HUMIRA(CF) Pen 40 mg/0.4 mls pharmaceutical supplies on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $5,330.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a injectable medication used to treat autoimmune conditions. The contract, with an ultimate completion date of September 10, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was made on a competitive basis with no...
- The Defense Logistics Agency awarded a $3,776.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, with an ultimate completion date of July 23, 2025. This competitive award, issued on July 22, 2025, carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The performance...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 15, 2025, valued at $100,235.63 for HUMIRA Pen 40MG/4ML (2 pens) under a firm fixed-price contract. The award, issued without a set-aside designation, is expected to be completed by October 10, 2025, with performance taking place at the awardee's Conshohocken facility. This delivery order is a child contract issued under AmerisourceBergen's...